Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Izotropic Corp (OP: IZOZF )

0.0930 -0.0109 (-10.49%)
Streaming Delayed Price Updated: 10:26 AM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,000
Open 0.0930
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1039
Today's Range 0.0930 - 0.1039
52wk Range 0.0538 - 0.2800
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Izotropic Provides Regulatory and Operational Updates
VANCOUVER, BC – TheNewswire - January 8, 2024 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed... 
Via TheNewswire.com
Exposures Product Safety
Izotropic Announces AGM Results
VANCOUVER, BC – TheNewswire - December 22, 2023 – Izotropic Corporation (“Izotropic” or the“Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed... 
Via TheNewswire.com

Performance

YTD
+3.33%
+3.33%
1 Month
-4.62%
-4.62%
3 Month
-16.06%
-16.06%
6 Month
-7.00%
-7.00%
1 Year
-62.80%
-62.80%

More News

Read More
Izotropic Completes Pre-Submission Meeting With U.S. FDA
Via TheNewswire.com
Exposures Product Safety
Izotropic Confirms FDA Pre-Submission Meeting Date
Via TheNewswire.com
Exposures Product Safety
Izotropic Corporation Announces Non-Brokered Private Placement
Via TheNewswire.com
Izotropic Files Class II Pre-Submission with FDA & Releases Details on Predicate Devices
Via TheNewswire.com
Exposures Product Safety
Izotropic Engages Market Awareness Consultant
Via TheNewswire.com
Izotropic Modifies Market Approval Pathway & Strategy
Via TheNewswire.com
Exposures Product Safety
Izotropic Completes QSUB Meeting With FDA Regarding Clinical Study Acceleration
Via TheNewswire.com
Exposures Product Safety
Izotropic Provides Business Update
Via TheNewswire.com
Izotropic to Extend Period for Unsecured Loans
Via TheNewswire.com
Izotropic's Izoview Breast CT Device to be Featured on Advancements TV Show in USA
Via TheNewswire.com
Izotropic Creates Compensation Committee and Adopts Charter
Via TheNewswire.com
Izotropic Releases First Video of IzoView
Via Newsfile
Izotropic Releases First Video of Izoview
Via TheNewswire.com
Izotropic Reports Board Meeting Results
Via TheNewswire.com
Izotropic Delays Announcements to 2023, Holds Board Meeting
Via TheNewswire.com
Izotropic Announces 2022 AGM Results and Clarifies Restating of Financial Statements
Via TheNewswire.com
Izotropic Completes Izoview Development and Assembly, Prepares for Final Testing
Via TheNewswire.com
Alexander Tokman Joins Izotropic Board Of Directors
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
IZOTROPIC CORPORATION Announces Closing of Non-Brokered Private Placement
Via TheNewswire.com
Izotropic Grants Stock Options
Via TheNewswire.com
Izotropic Implements Quality Management System for IzoView Breast CT Device Manufacturing
Via TheNewswire.com
Topics Product Recall Supply Chain
Exposures Legal Product Safety Supply Chain
Izotropic Appoints Medical Device R&D Expert as Executive VP of Product Engineering
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property
Izotropic Appoints Medical Device R&D Expert as Executive VP of Product Engineering
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.